- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07420504
A Longitudinal Study of Parental Sleep Intervention for Behavioral Insomnia in Early Childhood (SuSleep)
Efficacy of Parental Sleep Intervention on Infants and Toddlers With Behavioural Insomnia: A Longitudinal Follow-up Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children aged 0-3 years.
- Diagnosed with behavioural insomnia.
- Parental consent for participation.
Exclusion Criteria:
- Chronic diseases or history of head trauma.
- Other primary sleep disorders (e.g., OSA, narcolepsy, restless leg syndrome).
- Developmental delay, epilepsy, or other neurological/metabolic disorders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: infants and toddler with behavioural insomnia
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nighttime sleep efficiency measured by Actigraphy
Time Frame: Baseline, 1 month, 6 months and 12 months
|
Sleep efficiency is defined as the percentage of total sleep time (sleep period determined by the watch) to the total time spent in bed (from the time children try to fall asleep to the time they finally wake up in the morning). A higher percentage represents a more continuous and higher-quality night's sleep. Through the built-in accelerometer and other sensors, the actigraphy can be used to monitor an individual's activity level and sleep situation, thereby analysing the child's sleep patterns such as nighttime sleep efficiency. The team technician will export the relevant sleep indicators recorded by the actigraphy and calculate relevant outcome measure. Moreover, the actigraphy is validated with parental records of sleep diaries. |
Baseline, 1 month, 6 months and 12 months
|
|
Daytime napping pattern measured by Actigraphy
Time Frame: Baseline, 1 month, 6 months and 12 months
|
Record children's sleep behaviour during the day with the actigraphy. Two main indicators are evaluated:
This outcome measure is mainly reflected by the average time of daytime napping per day, which will be reported at different points to assess sleep-wake distribution throughout the day. |
Baseline, 1 month, 6 months and 12 months
|
|
Nocturnal awakening pattern measured by Actigraphy
Time Frame: Baseline, 1 month, 6 months, and 12 months
|
The actigraphy is used to objectively quantify wakefulness events during nighttime sleep. Two main indicators are evaluated:
This outcome measure is reflected by the average total duration of nocturnal awakenings per day, which will be reported to assess the degree of fragmentation of nighttime sleep. |
Baseline, 1 month, 6 months, and 12 months
|
|
Subjective sleep quality measured by the Brief Infant Sleep Questionnaires (BISQ)
Time Frame: Baseline, 1 month, 6 months, and 12 months
|
BISQ is a questionnaire tool used to assess the sleep of infants.
The questionnaire aims to collect information on infant sleep behaviour through parent-reported methods to help professionals more fully understand and evaluate infants' sleep quality and patterns.
This questionnaire evaluates the changes in children's sleep duration, co-sleeping situation, night-waking situation, falling-asleep situation, and overall sleep patterns.
|
Baseline, 1 month, 6 months, and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-regulating ability measured by the Age and Stage Questionnaires: Social and Emotional-2 (ASQ:SE-2)
Time Frame: Baseline, 1 month, 6 months, and 12 months
|
ASQ:SE-2 is a screening tool used to identify infants and young children who may be at risk for social or emotional difficulties. It relies on parents' or caregivers' observations of their child's behaviour. The questionnaire assesses a child's development across 8 specific behavioural dimensions:
|
Baseline, 1 month, 6 months, and 12 months
|
|
Temperament measured by the series of Carey Children Temperament Questionnaire
Time Frame: Baseline and 12 months
|
This instrument employs a standardized assessment to evaluate innate behavioral patterns and reactivity in infants.
Derived from the Thomas and Chess taxonomy, it measures core temperament dimensions including activity level, rhythmicity, adaptability, approach/withdrawal, threshold of responsiveness, intensity of reaction, quality of mood, distractibility, abd persistence.
The resulting profile aids in researching individual differences in developmental trajectories and informing individualized caregiving and educational strategies.
|
Baseline and 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parent stress measured by the Parent Stress Index (PSI)
Time Frame: Baseline, 6 months and 12 months
|
This scale is used to measure the parental stress of parents of children aged from 1 month to 12 years in three aspects, namely, parental distress, parent - child interaction disorder, and difficult child.
The total score ranges from 36 to 180.
A score of 85 or less indicates a normal level of parental stress.
A score between 86 and 90 represents a critically high level.
A score greater than 90 suggests a high level of parental stress, and a score of 99 or above indicates an extremely high level of parental stress.
|
Baseline, 6 months and 12 months
|
|
Occupational stress measured by the Chinese Version of Copenhagen Psychosocial Questionnaire (COPSOQ)
Time Frame: Baseline, 6 months and 12 months
|
This study adopts a short version, which mainly includes five modules: job requirements, personal influence and development, interpersonal relationship and leadership ability, job instability and job satisfaction.
The total score of the corresponding module can be obtained by calculating the sum of the average scores of the items to which the 5 modules belong.
Among them, the higher the scores of "job requirements" and "job instability", the more likely it is to cause occupational stress.
While the higher the scores of the other three modules means that it is less likely to cause occupational stress.
|
Baseline, 6 months and 12 months
|
|
Degree of caregiver's daytime sleepiness evaluated by the Epworth Sleepiness Scale (ESS)
Time Frame: Baseline, 1 month, 6 months, and 12 months
|
ESS is a standardized self-report questionnaire used to assess an individual's general level of daytime sleepiness.
It measures how likely a person is to doze off or fall asleep in 8 common, sedentary situations of daily life.
Each of the 8 situations is rated on a scale from 0 (no chance of dozing) to 3 (high chance of dozing).
The scores for all items are summed up to produce a total score ranging from 0 to 24.
The higher the score, the more severe the daytime sleepiness is, with a score of 10 or above indicating excessive daytime sleepiness.
|
Baseline, 1 month, 6 months, and 12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025CS038
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Behavioural Insomnia of Childhood
-
IWK Health CentreCompleted
-
Sungshin Women's UniversityNational Research Foundation of KoreaRecruitingBehavioral Insomnia of ChildhoodKorea, Republic of
-
Marmara UniversityCompletedEmotional Disorder of ChildhoodTurkey
-
Marmara UniversityNot yet recruitingInsomnia | Behavioral Insomnia of Childhood
-
Roxane LaboratoriesCompletedShort Term Treatment of InsomniaUnited States
-
Vastra Gotaland RegionGöteborg UniversityNot yet recruitingSurvivors of Childhood CancerSweden
-
Jonsson Comprehensive Cancer CenterWithdrawnSurvivors of Childhood CancerUnited States
-
Chinese University of Hong KongCompletedBehavioural and Psychiatric Symptoms of DementiaHong Kong
-
University of ZurichUniversity Children's Hospital BaselCompletedLate-effects of Childhood CancerSwitzerland
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
Clinical Trials on Sleep enhancement intervention
-
João BarreiraNot yet recruiting
-
University of Kansas Medical CenterCompleted
-
Hospital Clinica NovaActive, not recruiting
-
Northwestern UniversityUniversity of Virginia; Tiny Blue Dot FoundationCompletedAnxietyUnited States
-
Northwestern UniversityUniversity of VirginiaRecruiting
-
M.D. Anderson Cancer CenterTerminated
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingHypertension | PrehypertensionUnited States
-
University of ArizonaArizona Biomedical Research Commission (ABRC)UnknownSleep DeprivationUnited States
-
Massachusetts General HospitalBoston UniversityCompletedSocial Anxiety Disorder | Sleep LaboratoryUnited States
-
University of ZurichCompleted